Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia
Margherita Ghisi, Lev Kats, Frederick Masson, Jason Li, Tobias Kratina, Eva Vidacs, Omer Gilan, Maria A Doyle, Andrea Newbold, Jessica E Bolden, Kirsten A Fairfax, Carolyn A de Graaf, Matthew Firth, Johannes Zuber, Ross A Dickins, Lynn M Corcoran, Mark A Dawson, Gabrielle T Belz, Ricky W Johnstone
Cancer Cell | CELL PRESS | Published : 2016
Awarded by NHMRC
This work was funded by project and program grants (R.W.J.) from the National Health and Medical Research Council of Australia (NHMRC), a project grant from the Cancer Council Victoria (R.W.J.), the Victorian Cancer Agency (R.W.J.), Snowdome Foundation (R.W.J.), and an NHMRC Fellowship (R.W.J.). G.T.B. was supported by an NHMRC project grant (APP1047903) and an ARC Future fellowship. M.G. was supported by a Leukemia Foundation of Australia (LFA) Grant-in-Aid. M.A. Dawson was supported by the NHMRC, LFA, the Victorian Endowment for Science, Knowledge and Innovation (VESKI), and the Herman Trust. L.K., J.E.B., and C.A.d.G. were supported by Overseas-Based Biomedical Fellowships from the National Health and Medical Research Council of Australia. We thank Dr. P.J.M. Valk (Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands) for providing clinical data associated to GSE6891 dataset and Prof. D. Hilton for sharing unpublished data.